Examines the issues in medical ethics faced by doctors and their patients. This book also discusses the distinction and potential conflicts between legal and ethical obligations while making clinical decisions. It includes sections on: Genetic testing, Organ donation, Care of patients at the end of life, Health and human rights, and more.

This handbook is a much-needed and in-depth review of the distinctive set of ethical considerations which accompanies qualitative research. This is particularly crucial given the emergent, dynamic and interactional nature of most qualitative research, which too often allows little time for reflection on the important ethical responsibilities and obligations Contributions from leading international researchers have been carefully organised into six key thematic sections: Part One: Thick Descriptions Of Qualitative Research Ethics Part Two: Qualitative Research Ethics By Technique Part Three: Ethics As Politics Part Four: Qualitative Research Ethics With Vulnerable Groups Part Five: Relational Research Ethics Part Six: Researching Digitally This Handbook is a one-stop resource on qualitative research ethics across the social sciences that draws on the lessons learned and the successful methods for surmounting problems – the tried and true, and the new.

This ABA bestseller provides detailed guidance for compliance with the Lobbying Disclosure Act. It gives practical examples of how to be compliant, and covers all of the major federal statutes and regulations that govern the practice of federal lobbying. The book offers invaluable descriptions of the legislative and executive branch decision-making processes that lobbyists seek to influence, the constraints that apply to lobbyist participation in political campaigns, grassroots lobbying, ethics issues, and more.

The First Edition of the ACP Ethics Manual, published in 1984, has been updated to keep pace with current issues on medical ethics. Prepared by the ACP Ethics Committee, the Second Edition includes a greatly expanded section on initiating and withdrawing life-sustaining treatment. The ethics of cost conatinment and AIDS are addressed, and a subsection titled Medical Risk to the Physician has been added.